Comparison results
| Results: Differences General | ✘Gonorrheal vulvovaginitis | ✘The Arthus Phenomenon | |||||||||||||
| Related research | Analogs | Analogs | |||||||||||||
| |||||||||||||||
| Distinctive symptoms | |||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | |||||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 43% | |||||||||||||
| gonorrheal vulvovaginitis | 94% | — | |||||||||||||
| hyperchromia | — | 38% | |||||||||||||
| gonorrhea | 75% | — | |||||||||||||
| the arthus phenomenon | — | 37% | |||||||||||||
| vulva infections | 56% | — | |||||||||||||
| increased ast | — | 34% | |||||||||||||
| vulvovaginitis | 56% | — | |||||||||||||
| leukocyturia | — | 31% | |||||||||||||
| redness of the vulva | 43% | — | |||||||||||||
| proteinuria | — | 28% | |||||||||||||
| discharge from the urethra | 37% | — | |||||||||||||
| with reactive protein increased | — | 24% | |||||||||||||
| urethral syndrome | 37% | — | |||||||||||||
| protein with increased | — | 21% | |||||||||||||
| swelling with itching | 35% | — | |||||||||||||
| intolerance to drugs | — | 18% | |||||||||||||
| hyperemia of genitals | 34% | — | |||||||||||||
| increased sensitivity | — | 18% | |||||||||||||
| sensitivity of mucous membranes | 32% | — | |||||||||||||
| drug allergy | — | 18% | |||||||||||||
| postmenopause | 31% | — | |||||||||||||
| allergy | — | 17% | |||||||||||||
| conjunctivitis | 30% | — | |||||||||||||
| necrosis | — | 17% | |||||||||||||
| childhood diseases | 29% | — | |||||||||||||
| drug disease | — | 16% | |||||||||||||
| peritonitis | 28% | — | |||||||||||||
| main complaint is allergy | — | 15% | |||||||||||||
| arthritis | 25% | — | |||||||||||||
| allergy to antibiotics | — | 15% | |||||||||||||
| joint diseases | 23% | — | |||||||||||||
| lot of plans | — | 13% | |||||||||||||
| inflammation | 28% | 7% | |||||||||||||
| controls itself | — | 12% | |||||||||||||
| unbearable pain | 27% | 9% | |||||||||||||
| leukocytosis | — | 12% | |||||||||||||
| itchy skin | 25% | 12% | |||||||||||||
| wound | — | 11% | |||||||||||||
| soreness of the skin | 23% | 11% | |||||||||||||
| severe itching of the skin | — | 11% | |||||||||||||
| swelling | 21% | 10% | |||||||||||||
| dense swelling | — | 11% | |||||||||||||
| acute pain | 22% | 11% | |||||||||||||
| consequence of hormone treatment | — | 11% | |||||||||||||
| lowered | 19% | 12% | |||||||||||||
| changes in urine | — | 10% | |||||||||||||
| increased | 19% | 15% | |||||||||||||
| serum sickness | — | 10% | |||||||||||||
| effects of taking hormones | — | 10% | |||||||||||||
| indecision | — | 10% | |||||||||||||
| allergy to the skin | — | 10% | |||||||||||||
| skin problems | — | 10% | |||||||||||||
| dermatosis | — | 10% | |||||||||||||
| feeling lonely | — | 10% | |||||||||||||
| consequences of taking medications | — | 10% | |||||||||||||
| allergy to medications | — | 9% | |||||||||||||
| history of surgery | — | 9% | |||||||||||||
| vaccination | — | 9% | |||||||||||||
| wounds heal poorly | — | 9% | |||||||||||||
| scratch | — | 9% | |||||||||||||
| oily skin | — | 9% | |||||||||||||
| rapid reaction | — | 9% | |||||||||||||
| I can't be alone | — | 9% | |||||||||||||
| muscle damage | — | 9% | |||||||||||||
| diabetes mellitus | — | 8% | |||||||||||||
| surgical infections | — | 8% | |||||||||||||
| headaches | — | 8% | |||||||||||||
| blood diseases | — | 7% | |||||||||||||
| patient's condition | — | 7% | |||||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
